Revenue Growth MomentumRe-accelerated revenue growth (~+10.7% in 2026) indicates improving demand for respiratory products and stronger market traction. Sustained top-line expansion supports scale economics, funds reinvestment in product lines, and underpins medium-term competitiveness.
Improved Balance Sheet / Lower LeverageMeaningful leverage reduction (debt-to-equity ~0.30) materially strengthens financial flexibility and lowers refinancing risk. A more conservative capital structure supports targeted capex, working-capital resilience and the ability to endure industry downdrafts over coming quarters.
Recurring Consumable RevenueThe core business includes recurring sales of filters, cartridges and replacement parts tied to safety compliance. Consumable-driven revenue creates predictable, repeatable cash inflows, enhances customer stickiness and supports revenue visibility across multiple quarters.